Impact of Pirfenidone on Arrhythmic and Clinical Outcomes in Patients With Idiopathic Pulmonary Fibrosis
Pirfenidone use to treat IPF was associated with fewer arrhythmic events and less diastolic dysfunction compared to patients who did not use pirfenidone during long-term follow-up. Additionally, obesity is associated with a higher incidence of arrhythmic events in patients with IPF.
Authors
- Soo Jin Kim
- Jung Ho Heo
- Su Hyun Bae
- Sung Il Im
- Edward P. Gerstenfeld
- Tae Won Jang
- Bong Joon Kim
Institutions
- University of California, San Francisco (US)
- Kosin University Gospel Hospital (KR)
- San Diego Cardiac Center (US)
Publication Details
- Journal
- Journal of Cardiovascular Electrophysiology
- Published
- 2026-01-26
- DOI
- https://doi.org/10.1111/jce.70269
- Primary Topic
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Kosin University
- University of California, San Francisco